Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Mini Review
  • Published:

Digital hypertension in 2024–2025: emerging evidence and future directions

Hypertension Research volume 49, pages 1343–1348 (2026)Cite this article

Abstract

Recent advances in digital technology are remarkable, and they are driving profound transformations in healthcare and medical research. Within this context, digital hypertension has emerged as a multidisciplinary paradigm that integrates novel digital technologies into the prevention, diagnosis, and management of hypertension. Digital hypertension encompasses diverse domains such as advanced sensor development, continuous physiological monitoring, information processing, artificial intelligence, big data analytics, digital therapeutics, and telemedicine. These innovations enable more personalized, efficient, and data-driven hypertension care. A growing body of research has explored applications ranging from home-based blood pressure monitoring systems to AI-assisted risk prediction models and remote therapeutic interventions, producing promising and clinically relevant outcomes. This review summarizes the latest evidence, highlights technological and clinical advances, and discusses future perspectives and challenges for the broader adoption of digital hypertension strategies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Matsuoka R, Akazawa H, Kodera S, Komuro I. The dawning of the digital era in the management of hypertension. Hypertens Res. 2020;43:1135–40.

    Article  PubMed  Google Scholar 

  2. Kario K, Hoshide S, Mogi M. Digital hypertension 2023: Concept, hypothesis, and new technology. Hypertens Res. 2022;45:1529–30.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kario K, Williams B, Tomitani N, McManus RJ, Schutte AE, Avolio A, et al. Innovations in blood pressure measurement and reporting technology: International Society of Hypertension position paper endorsed by the World Hypertension League, European Society of Hypertension, Asian Pacific Society of Hypertension, and Latin American Society of Hypertension. J Hypertens. 2024;42:1874–88.

    Article  CAS  PubMed  Google Scholar 

  4. Kario K, Asayama K, Arima H, Matsumoto C, Nakagawa N, Nomura A, et al. Digital hypertension - what we need for the high-quality management of hypertension in the new era. Hypertension Res. 2025;48:3130–3146.

  5. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45:3912–4018.

    Article  PubMed  Google Scholar 

  6. Stergiou GS, Avolio AP, Palatini P, Kyriakoulis KG, Schutte AE, Mieke S, et al. European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices: European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. J Hypertens. 2023;41:2074–87.

    Article  CAS  PubMed  Google Scholar 

  7. Tomitani N, Hoshide S, Kario K. Could wristwatch-type wearable oscillometric blood pressure monitoring be a third option for out-of-office blood pressure monitoring? Hypertens Res. 2024;47:1078–80.

    Article  PubMed  Google Scholar 

  8. Lee WL, Danaee M, Abdullah A, Wong LP. Is the Blood Pressure-Enabled Smartwatch Ready to Drive Precision Medicine? Supporting Findings From a Validation Study. Cardiol Res. 2023;14:437–45.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Tomitani N, Hoshide S, Kanegae H, Kario K, HI-JAMP Study Group. Daytime actisensitivity predicts nocturnal dipping patterns and morning surge in blood pressure: the Home-Activity ICT-based Japan Ambulatory Blood Pressure Monitoring Prospective study. J Hypertens. 2024;42:2164–72.

    Article  CAS  PubMed  Google Scholar 

  10. Koyama M, Himuro N, Nakata K, Oyatani K, Shinohara Y, Ohnishi H, et al. Effects of physical activity-promoting wearable devices on blood pressure in adults: a systematic review and meta-analysis. Hypertens Res. 2025 (e-pub ahead of print 2025/07/30;https://doi.org/10.1038/s41440-025-02260-6).

  11. Yousefi F, Naye F, Ouellet S, Yameogo AR, Sasseville M, Bergeron F, et al. Artificial intelligence in health promotion and disease reduction: rapid review. J Med Internet Res. 2025;27:e70381.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Shimbo D, Shah RU, Abdalla M, Agarwal R, Ahmad FS, Anaya G, et al. Transforming hypertension diagnosis and management in the era of artificial intelligence: a 2023 National Heart, Lung, and Blood Institute (NHLBI) workshop report. Hypertension. 2025;82:36–45.

    Article  CAS  PubMed  Google Scholar 

  13. Oikonomou EK, Spatz ES, Suchard MA, Khera R. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials. Lancet Digit Health. 2022;4:e796–e805.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Samal L, Kilgallon JL, Lipsitz S, Baer HJ, McCoy A, Gannon M, et al. Clinical decision support for hypertension management in chronic kidney disease: a randomized clinical trial. JAMA Intern Med. 2024;184:484–92.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Liu L, Guo J, Jiao X, You L. The effect of digital therapeutics intervention on improving hypertension management in adults: a meta-analysis of randomized controlled trial. Hypertens Res. 2025;48:456–69.

    Article  PubMed  Google Scholar 

  16. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67.

    Article  PubMed  Google Scholar 

  17. Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T, et al. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. Eur Heart J. 2021;42:4111–22.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Katsuya T, Hisaki F, Aga M, Hirayama Y, Takagi Y, Ichikihara Y, et al. Digital therapeutic for hypertension improves physician-patient communication and clinical inertia: a survey of physicians who implemented CureApp HT in clinical practice. Hypertens Res. 2025;48:470–7.

    Article  PubMed  Google Scholar 

  19. Abe M, Hirata T, Morito N, Kawashima M, Yoshida S, Takami Y, et al. Smartphone application-based intervention to lower blood pressure: a systematic review and meta-analysis. Hypertens Res. 2025;48:492–505.

    Article  PubMed  Google Scholar 

  20. Nagappan A, Krasniansky A, Knowles M. Patterns of ownership and usage of wearable devices in the United States, 2020–2022: survey study. J Med Internet Res. 2024;26:e56504.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chandrasekaran R, Sadiq TM, Moustakas E. Usage trends and data sharing practices of healthcare wearable devices among US adults: cross-sectional study. J Med Internet Res. 2025;27:e63879.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan

    Naoko Tomitani & Kazuomi Kario

Authors
  1. Naoko Tomitani
    View author publications

    Search author on:PubMed Google Scholar

  2. Satoshi Hoshide
    View author publications

    Search author on:PubMed Google Scholar

  3. Kazuomi Kario
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Naoko Tomitani.

Ethics declarations

Conflict of interest

KK has received research grants from Omron Healthcare and A&D Co. The other authors have no conflicts of interest to declare.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tomitani, N., Hoshide, S. & Kario, K. Digital hypertension in 2024–2025: emerging evidence and future directions. Hypertens Res 49, 1343–1348 (2026). https://doi.org/10.1038/s41440-026-02554-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41440-026-02554-3

Keywords

Search

Advanced search

Quick links